FDA's elevated meeting status signals transition from biomarker data discussions to Accelerated Approval discussions OS ...

Discover why biomarkers are critical in modern drug discovery and clinical trials, enabling better target validation.

Investors are scrutinizing the prospects for some drugs in the pipeline following a string of recent rejections from the U.S.

MIRAMAR, Fla., March 11, 2026 /PRNewswire/ -- DifGen Pharmaceuticals LLC, a U.S.-based specialty generic pharmaceutical company today announced that the U.S. Food and Drug Administration (FDA) has ...

Interim observations from the Phase 2 TRAILHEAD study show continued improvement in handgrip strength, overall stability of elbow and shoulder strength in new dynamometry measurements Greater ...

The metabolism–cancer axis is currently at a critical inflection point. A landmark August 2025 JAMA Oncology study reported a 17% reduction in overall ...

Many people know that finding cancer early, before it spreads, may help increase the chances of treating and surviving cancer.1 But navigating risk factors and getting ahead can ...

Two former FDA veterans are worried that a "firewall" between politics and scientific regulatory decisions has been breached, risking the agency's reputation and leadership.

New analysis of Gazyva® shows the drug significantly reduces disease activity in adults with systemic lupus erythematosus.

BECKVILLE, TX - March 11, 2026 - PRESSADVANTAGE - RestoPros of Tyler-Longview-Nacogdoches today outlined the essential ...

The collaboration brings together Scipher Medicine’s expertise in precision medicine and molecular patient stratification with Senelix’s therapeutic development capabilities to accelerate the ...

Nicole Zamore is a distinguished project management and organizational development professional whose career is defined by purpose, impact, and servant leadership. With over a decade of experience ...